SS Innovations International (SSII) Cash & Equivalents Growth (3y) (2019 - 2026)
Powered by 
Analysis
SS Innovations International (SSII) Cash & Equivalents Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -2.57% |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 32.23% |
| 10 | SS Innovations International | 682.58 Mn | 660.28 Mn | 7.10 Mn | 218.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 218.33% |
| Mar 31, 2026 | 229.04% |
| Dec 31, 2025 | 145.32% |
| Sep 30, 2025 | 122.74% |
| Jun 30, 2025 | 251.88% |
| Mar 31, 2025 | 257.68% |
| Dec 31, 2024 | 4.76% |
| Sep 30, 2024 | 2.40% |
| Jun 30, 2024 | 25.52% |
| Mar 31, 2024 | 44.11% |
| Dec 31, 2023 | 132.59% |
| Sep 30, 2023 | 2,027.49% |
| Jun 30, 2023 | 327.47% |
| Mar 31, 2023 | 253.90% |
| Dec 31, 2022 | 96.84% |
| Sep 30, 2022 | 157.92% |
| Jun 30, 2022 | 88.32% |
| Mar 31, 2022 | 77.98% |
| Dec 31, 2021 | 124.81% |
| Sep 30, 2021 | 27.00% |